Alterations of corticotropin-releasing factor-like immunoreactivity in different brain regions after acute cocaine administration in rats

1993 ◽  
Vol 616 (1-2) ◽  
pp. 315-319 ◽  
Author(s):  
Zoltán Sarnyai ◽  
Éva Bíró ◽  
János Gardi ◽  
Miklós Vecsernyés ◽  
János Julesz ◽  
...  
1993 ◽  
Vol 238 (2-3) ◽  
pp. 425-429 ◽  
Author(s):  
Javaid I. Javaid ◽  
Sanjeev K. Sahni ◽  
Subhash C. Pandey ◽  
John M. Davis

CNS Spectrums ◽  
2008 ◽  
Vol 13 (7) ◽  
pp. 585-591 ◽  
Author(s):  
Jyotsna Nair ◽  
Sarbjot Singh Ajit

ABSTRACTAntiglutamatergic agents, such as lamotrigine, have been used successfully for the treatment of posttraumatic stress disorder (PTSD). They could be potentially acting through the stabilization of the corticotropin-releasing factor (CRF) systems. Glutamate mediates CRF release in various brain regions involved in the pathophysiology of PTSD, antiglutamatergic agents could stabilize the CRF system and, thereby, improve the symptom complex of PTSD (reexperiencing, hyperarousal, and avoidance). The role of glutamate and CRF in PTSD and other anxiety disorders are still being elucidated. However, it is clear that the glutamatergic systems play a role in the pathophysiology of PTSD.


2021 ◽  
Vol 239 (4) ◽  
pp. 1179-1191
Author(s):  
Barbara dos Anjos Rosário ◽  
Maria de Fátima Santana de Nazaré ◽  
Jéssica Alves Lemes ◽  
José Simões de Andrade ◽  
Regina Barbosa da Silva ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document